: Our Impact

Photo: From left: Johnnie Amenyah of JSI, Gladys Tetteh, Francis Aboagye-Nyame, Dinah Tjipura, and Kwesi Eghan of the SIAPS Program attending the End-of-Program event on March 1, 2018 in Arlington, VA. (Santita Ngo/MSH) On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program.

Photo: From left: Johnnie Amenyah of JSI, Gladys Tetteh, Francis Aboagye-Nyame, Dinah Tjipura, and Kwesi Eghan of the SIAPS Program attending the End-of-Program event on March 1, 2018 in Arlington, VA. (Santita Ngo/MSH) On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program.

Photo: From left: Johnnie Amenyah of JSI, Gladys Tetteh, Francis Aboagye-Nyame, Dinah Tjipura, and Kwesi Eghan of the SIAPS Program attending the End-of-Program event on March 1, 2018 in Arlington, VA. (Santita Ngo/MSH) On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program.

Photo: From left: Johnnie Amenyah of JSI, Gladys Tetteh, Francis Aboagye-Nyame, Dinah Tjipura, and Kwesi Eghan of the SIAPS Program attending the End-of-Program event on March 1, 2018 in Arlington, VA. (Santita Ngo/MSH) On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program.

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.

Pages

Printer Friendly Version